Capricor Therapeutics (CAPR) Q2 2023 Earnings

7AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.35
-0.32
-0.29
-0.26

Details

Expected EPS
-0.35
Actual EPS
-0.29
Surprise EPS
0.06
Surprise Percent
+17.14%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.29 per share for Q2 2023.

0 Comments

Share your thoughts